Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended		18 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Consolidated net loss	$ (22,680,898)	$ (327,115)	$ (23,569,969)
Adjustments to reconcile consolidated net loss to net cash used in operating activities:
Stock compensation expense	2,178,590	0	2,265,084
Stock issued in connection with in-licensing agreement	16,578,000	297,000	16,875,000
Depreciation	118	0	118
Change in fair value and accrued interest of notes payable	(284,297)	0	(284,297)
Changes in assets and liabilities, net of effects of acquisition:
Increase in prepaid and other current assets	(1,697,304)	0	(1,693,711)
Increase in accounts payable related party, other accounts payable and accrued expenses	1,505,531	0	1,913,841
Increase in interest payable	45,628	0	52,725
Net cash used in operating activities	(4,354,632)	(30,115)	(4,441,209)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(1,399)	0	(1,399)
Cash acquired in connection with acquisition	0	0	10,386
Net cash (used in) provided by investing activities	(1,399)	0	8,987
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of short-term loans	(200,000)	0	(200,000)
Proceeds from sale of common stock, net	0	30,115	9,824,682
Proceeds from sale of preferred stock, net	12,257,309	0	12,257,309
Offering costs paid	(75,903)	0	(75,903)
Net cash provided by financing activities	11,981,406	30,115	21,806,088
NET INCREASE IN CASH AND CASH EQUIVALENTS	7,625,375	0	17,373,866
Cash and cash equivalents at beginning of period	9,748,491	0	0
CASH AND CASH EQUIVALENTS AT END OF PERIOD	17,373,866	0	17,373,866
NONCASH TRANSACTIONS:
Conversion of notes payable to preferred stock	0	0	55,271
Accrued financing costs	$ 0	$ 0	$ 116,626